Mirko Scherer
Direktor/Vorstandsmitglied bei APTORUM GROUP LIMITED
Profil
Mirko Scherer was the founder of GPC Biotech AG, founded in 1997 where he held the title of Chief Financial Officer until 2007, and Charly SpA, founded in 2016 where he held the title of Chief Technology Officer.
Currently, he is the Chief Executive Officer at TVM Capital China Ltd.
since 2015 and an Independent Non-Executive Director at Aptorum Group Ltd.
since 2017.
His former positions include Co-Managing Director at KI Kapital GmbH from 2008 to 2014, Director at Börse Frankfurt from 2005 to 2007, Director at China BioPharma Capital I GP from 2015 to 2017, Non-Executive Director at Quantapore, Inc. from 2016 to 2018, and Director at Stichting Preferente Aandelen Qiagen from 2004 to 2019.
Dr. Scherer received his undergraduate degree from the University of Mannheim in 1993, his MBA from Harvard Business School in 1996, and his doctorate from EBS Universität für Wirtschaft und Recht gGmbH in 1998.
Aktive Positionen von Mirko Scherer
| Unternehmen | Position | Beginn |
|---|---|---|
| APTORUM GROUP LIMITED | Direktor/Vorstandsmitglied | 01.10.2017 |
Charly SpA
 Charly SpA Packaged SoftwareTechnology Services Charly SpA is a Chilean company that offers an automated financial advisory platform for startups. The company is based in Las Condes, Chile. It was founded by Diego Borquez, Sebastian Ibanez, and Mirko Scherer, with Diego Borquez serving as the CEO since incorporation. | Gründer | 01.03.2016 |
| TVM Capital China Ltd. | Vorstandsvorsitzender | 01.03.2015 |
Ehemalige bekannte Positionen von Mirko Scherer
| Unternehmen | Position | Ende |
|---|---|---|
| Stichting Preferente Aandelen Qiagen | Direktor/Vorstandsmitglied | 01.01.2019 |
Quantapore, Inc.
 Quantapore, Inc. BiotechnologyHealth Technology Quantapore, Inc. develops nanopore based nucleic acid sequencing technology products. The firm's proprietary DNA sequencing technology is based on an optically labeled nanopore which interacts via energy transfer with a labeled nucleic acid sample. The company was founded by Martin Huber and Sascha C. Dennstedt in 2009 and is headquartered in Menlo Park, CA. | Direktor/Vorstandsmitglied | 01.07.2018 |
| China BioPharma Capital I GP | Direktor/Vorstandsmitglied | 01.09.2017 |
KI Kapital GmbH
 KI Kapital GmbH Investment ManagersFinance KI Kapital operates as a entrepreneurial consulting and private equity company. It support companies during growth phases both through consulting regarding strategic and operational challenges as well as through investments. The company was founded in 2009 and is base in Muchen, Germany. | Corporate Officer/Principal | 01.02.2014 |
GPC Biotech AG
 GPC Biotech AG Miscellaneous Commercial ServicesCommercial Services GPC Biotech AG is a biotechnology company discovering and developing new anticancer drugs.It is headquartered in Martinsried/Munich (Germany). The Company's wholly owned U.S. subsidiary has research and development sites in Waltham, Massachusetts and Princeton, New Jersey | Gründer | 04.12.2007 |
Ausbildung von Mirko Scherer
| EBS Universität für Wirtschaft und Recht gGmbH | Doctorate Degree |
| Harvard Business School | Masters Business Admin |
| University of Mannheim | Undergraduate Degree |
Erfahrungen
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Beziehungen
Beziehungen ersten Grades
Unternehmen ersten Grades
Herr
Frau
Aufsichtsräte
Führungskräfte
Unternehmensverbindungen
| Börsennotierte Unternehmen | 1 |
|---|---|
| APTORUM GROUP LIMITED | Health Technology |
| Private Unternehmen | 8 |
|---|---|
GPC Biotech AG
GPC Biotech AG Miscellaneous Commercial ServicesCommercial Services GPC Biotech AG is a biotechnology company discovering and developing new anticancer drugs.It is headquartered in Martinsried/Munich (Germany). The Company's wholly owned U.S. subsidiary has research and development sites in Waltham, Massachusetts and Princeton, New Jersey | Commercial Services |
KI Kapital GmbH
KI Kapital GmbH Investment ManagersFinance KI Kapital operates as a entrepreneurial consulting and private equity company. It support companies during growth phases both through consulting regarding strategic and operational challenges as well as through investments. The company was founded in 2009 and is base in Muchen, Germany. | Finance |
Quantapore, Inc.
Quantapore, Inc. BiotechnologyHealth Technology Quantapore, Inc. develops nanopore based nucleic acid sequencing technology products. The firm's proprietary DNA sequencing technology is based on an optically labeled nanopore which interacts via energy transfer with a labeled nucleic acid sample. The company was founded by Martin Huber and Sascha C. Dennstedt in 2009 and is headquartered in Menlo Park, CA. | Health Technology |
Charly SpA
Charly SpA Packaged SoftwareTechnology Services Charly SpA is a Chilean company that offers an automated financial advisory platform for startups. The company is based in Las Condes, Chile. It was founded by Diego Borquez, Sebastian Ibanez, and Mirko Scherer, with Diego Borquez serving as the CEO since incorporation. | Technology Services |
Börse Frankfurt
 Börse Frankfurt Investment Banks/BrokersFinance Frankfurt Stock Exchange operates as stock market. It provides free information includes free stock quotes, DAX and other information, information on selected companies traded and listed in the stock exchange. It also provides direct source for global investors to find up-to-date public information on Frankfurt listed stocks and bonds, featured companies and trading. The company was founded on 1585 and is headquartered in Frankfurt, Germany. | Finance |
| Stichting Preferente Aandelen Qiagen | |
| TVM Capital China Ltd. | |
| China BioPharma Capital I GP | Finance |
